Literature DB >> 23023430

Poor insight into memory impairment in patients with Huntington disease.

Emilia J Sitek1, Witold Sołtan, Piotr Robowski, Michał Schinwelski, Dariusz Wieczorek, Jarosław Sławek.   

Abstract

BACKGROUND AND
PURPOSE: Patients suffering from Huntington disease (HD) have been shown to present with poor self-awareness of a variety of symptoms. The study aimed to assess the self-awareness of memory impairment in HD in comparison to advanced Parkinson disease (PD), mild PD and cervical dystonia.
MATERIAL AND METHODS: Self-awareness was tested in 23 patients with HD by comparing patient and caregiver ratings in reference to clinical control groups (25 patients with advanced PD, 21 with mild PD and 20 with cervical dystonia). Self-awareness was tested using the Self Rating Scale of Memory Functions, which was administered to both the patients and the caregivers. Neuropsychological assessment addressed general cognitive status (Mini-Mental State Examination), verbal learning (Auditory Verbal Learning Test, 15-word list) and mood (Montgomery-Asberg Depression Rating Scale).
RESULTS: Patients with HD significantly underestimated their memory dysfunction. Underestimation of memory deficit correlated with disease duration and disease severity in HD.
CONCLUSIONS: Huntington disease patients underestimate memory dysfunction. These results add to the previous reports on poor insight in HD in other domains and suggest that anosognosia in HD, albeit usually rather mild, may be a generalized phenomenon.

Entities:  

Mesh:

Year:  2012        PMID: 23023430     DOI: 10.5114/ninp.2012.30262

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  5 in total

1.  Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Joel S Perlmutter; Kelvin L Chou; Julie C Stout; Jane S Paulsen; Michael K McCormack; David Cella; Martha A Nance; Jin-Shei Lai; Praveen Dayalu
Journal:  J Neurol       Date:  2018-04-23       Impact factor: 4.849

Review 2.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014

3.  Awareness of memory deficits in early stage Huntington's disease.

Authors:  Laurent Cleret de Langavant; Gilles Fénelon; Sarah Benisty; Marie-Françoise Boissé; Charlotte Jacquemot; Anne-Catherine Bachoud-Lévi
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

4.  HD-PRO-TRIAD™ Validation: A Patient-reported Instrument for the Symptom Triad of Huntington's Disease.

Authors:  Noelle E Carlozzi; David Victorson; Victor Sung; Jennifer L Beaumont; Wendy Cheng; Brian Gorin; Mei Sheng Duh; David Samuelson; David Tulsky; Sandra Gutierrez; Cindy J Nowinski; Allison Mueller; Vivienne Shen; Samuel Frank
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-04-14

5.  The prescriptions from Shenghui soup enhanced neurite growth and GAP-43 expression level in PC12 cells.

Authors:  Qi Zhang; Zi-Jian Zhang; Xing-Hua Wang; Jie Ma; Yue-Han Song; Mi Liang; Sen-Xiang Lin; Jie Zhao; Ao-Zhe Zhang; Feng Li; Qian Hua
Journal:  BMC Complement Altern Med       Date:  2016-09-20       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.